| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |